For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Phase I/II: ABT-751 | Phase I: Patients receive oral ABT-751 twice daily on days 1-7 and 15-21. Phase II: Patients receive ABT-751 at 125mg twice daily, 7 days on, 7 days off (x2)for a 28-day cycle | None | None | 7 | 27 | 27 | 27 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| pain, tumor | None | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| hemoglobin | None | Blood and lymphatic system disorders | None | View |
| mood alteration | None | Psychiatric disorders | None | View |
| dehydration | None | Metabolism and nutrition disorders | None | View |
| nausea | None | Gastrointestinal disorders | None | View |
| vomiting | None | Gastrointestinal disorders | None | View |
| hyperglycemia | None | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| confusion | None | Psychiatric disorders | None | View |
| neuropathy cranial | None | Nervous system disorders | None | View |
| neuropathy motor weakness | None | Nervous system disorders | None | View |
| speech impairment | None | Nervous system disorders | None | View |
| extrapyramidal | None | Nervous system disorders | None | View |
| fever | None | General disorders | None | View |
| Infection with normal ANC | None | Infections and infestations | None | View |
| memory impairment | None | Psychiatric disorders | None | View |
| Fecal incontinence | None | Gastrointestinal disorders | None | View |
| back pain | None | Musculoskeletal and connective tissue disorders | None | View |
| extremity pain | None | Musculoskeletal and connective tissue disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Constipation | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| neuropathy | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| hyperglycemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| gastrointestinal disorders | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| fatigue | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| anorexia | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| diarrhea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| alkaline phosphatase increase | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| depression | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| confusion | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| dehydration | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| hypokalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| fever | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| weight loss | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| sweats | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| hypophosphatemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| neutrophil count decreased | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| hyponatremia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| thrombosis | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| hyperuricemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| dyspnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| xerostomia | None | Gastrointestinal disorders | None | View |
| elevated transaminases | None | Metabolism and nutrition disorders | None | View |
| hematuria | None | Renal and urinary disorders | None | View |
| urine retention | None | Renal and urinary disorders | None | View |
| renal failure | None | Renal and urinary disorders | None | View |